SCHEMBL25823465

SCHEMBL25823465

C=C(CCC)C(=O)Oc1c(C)cc(C)cc1C

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
POLB P06746 3/20 0.34
HPGD P15428 1/20 0.34
ALDH1A1 P00352 4/20 0.33
KDM4E B2RXH2 4/20 0.33
GAA P10253 2/20 0.33
NLRP3 Q96P20 1/20 0.33
MIF P14174 1/20 0.32
THRA P10827 1/20 0.32
THRB P10828 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
TDP1 Q9NUW8 1/20 0.31
GLA P06280 1/20 0.31
KMT2A Q03164 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7394143 0.79 ALDH1A1 (0.43) CYP1A2CYP3A4CYP2C19POLBHPGD
SCHEMBL1521059 0.77 ELANE (0.39) POLBALDH1A1KDM4EGAAMIF
SCHEMBL9575172 0.75 KDM4E (0.33) POLBALDH1A1KDM4EGAAMIF
SCHEMBL14678813 0.75 SRC (0.33) POLBKDM4EGAASMN1; SMN2KMT2A
SCHEMBL8866848 0.71 ALOX15 (0.46) POLBHPGDKDM4ETHRATHRB
SCHEMBL632667 0.71 S1PR2 (0.32) POLBALDH1A1KDM4EKMT2AL3MBTL1
SCHEMBL8396488 0.71 ACHE (0.45) POLBHPGDALDH1A1KDM4EGAA
SCHEMBL16837506 0.70 DGKA (0.46) THRATHRBSMN1; SMN2KMT2A
SCHEMBL15509359 0.69 RAPGEF4 (0.40) POLBALDH1A1KDM4EGAAMIF
SCHEMBL6892583 0.69 ALDH1A1 (0.46) CYP1A2CYP3A4CYP2C19ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230212136-A1 CURABLE RESIN COMPOSITION, CURED PRODUCT, DIFFRACTIVE OPTICAL ELEMENT, AND MULTILAYER DIFFRACTIVE OPTICAL ELEMENT FUJIFILM CORPORATION (JP) 2023-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230212136-A1 CURABLE RESIN COMPOSITION, CURED PRODUCT, DIFFRACTIVE OPTICAL ELEMENT, AND MULTILAYER DIFFRACTIVE OPTICAL ELEMENT TERB1, RER1, LARP1 CYP1A2 1900/4885CYP3A4 2849/4885CYP2C19 2342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.